JERUSALEM, March 4, 2015 /PRNewswire/ —
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the company will participate in the upcoming 27th Annual ROTH Conference, taking place March 8-11, 2015 in Dana Point, CA. Dr. Michael Berelowitz, Chairman of the Scientific Advisory Board of Oramed, will present a corporate overview on March 10, 2015.
The 27th Annual ROTH Conference
Date: Tuesday, March 10, 2015
Time: 12:30pm PT
Location: The Ritz Carlton, Salon 2 Presentation Hall
About Oramed Pharmaceuticals
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed’s Protein Oral Delivery (POD